2001
DOI: 10.1016/s0028-3908(01)00074-0
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

14
61
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(76 citation statements)
references
References 10 publications
14
61
1
Order By: Relevance
“…Of the heteromeric receptors, only 5-HT 3 AB receptors have been extensively characterized and, compared to homomeric 5-HT 3 A, 5-HT 3 AB receptors differ in their EC 50 , Hill slope, desensitization kinetics, shape of current-voltage relationship, and most noticeably, a much larger single-channel conductance (y16 pS in 5-HT 3 AB compared to <1 pS in 5-HT 3 A ; Davies et al 1999 ;Dubin et al 1999). However, the pharmacology of 5-HT 3 A and 5-HT 3 AB receptors is almost identical, suggesting that they contain a common binding site (an A-A interface), a hypothesis supported by a recent study of mouse 5-HT 3 AB receptors (Brady et al 2001 ;, but conflicting with the BABBA arrangement determined using atomic force microscopy (Barrera et al 2005). The subunit types and stoichiometry of 5-HT 3 Rs have been recently reviewed (Barnes et al 2009 ;Jensen et al 2008).…”
Section: +mentioning
confidence: 99%
“…Of the heteromeric receptors, only 5-HT 3 AB receptors have been extensively characterized and, compared to homomeric 5-HT 3 A, 5-HT 3 AB receptors differ in their EC 50 , Hill slope, desensitization kinetics, shape of current-voltage relationship, and most noticeably, a much larger single-channel conductance (y16 pS in 5-HT 3 AB compared to <1 pS in 5-HT 3 A ; Davies et al 1999 ;Dubin et al 1999). However, the pharmacology of 5-HT 3 A and 5-HT 3 AB receptors is almost identical, suggesting that they contain a common binding site (an A-A interface), a hypothesis supported by a recent study of mouse 5-HT 3 AB receptors (Brady et al 2001 ;, but conflicting with the BABBA arrangement determined using atomic force microscopy (Barrera et al 2005). The subunit types and stoichiometry of 5-HT 3 Rs have been recently reviewed (Barnes et al 2009 ;Jensen et al 2008).…”
Section: +mentioning
confidence: 99%
“…Competitive antagonists of 5-HT 3 receptors are used clinically as antiemetics in cancer chemotherapy and in general anesthesia, although other applications are being explored (13). The two receptor subtypes are difficult to distinguish pharmacologically (14), although picrotoxin (15) and tubocurarine (7) are markedly less potent in blocking agonist-induced currents in the exogenously expressed heteromeric receptors. Although there is some anatomical evidence that the homomeric receptor may be expressed alone in the rat (16,17), current functional evidence suggests that it is the heteromer that is of major importance both centrally and in the periphery.…”
mentioning
confidence: 99%
“…Only 5-HT 3A subunits are able to form functional homo-oligomeric receptors, whereas the 5-HT 3B , C , D and E subunits cannot build a functional homopentameric receptor on their own [1-3,5,6]. Although heteromeric 5-HT 3A/X receptors show individual differences compared to homomeric 5-HT 3A receptors, the overall pharmacological profiles are similar [3,7]. By contrast, structurally different compounds and 5-HT 3 receptors of diverse composition may very likely present distinct pharmacological properties.…”
Section: Human 5-ht 3 Receptor Systemmentioning
confidence: 99%